This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PRELIMINARY REPORT

BÉLA SCHICK, M.D.; HARRY SOBOTKA, PH.D.; SAMUEL PECK, M.D.

Am J Dis Child. 1933;45(6):1216-1220.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

For the past five years one of us (Dr. Schick) has been studying the disease that follows the administration of nirvanol (phenyl-ethylhydantoin), the drug used so widely in the treatment of chorea. The name "nirvanol sickness" was originated by von Pfaundler, who compared the disease with serum disease. There exist in both diseases a time of incubation of similar duration, a fever, rash, edema, leukopenia with relative lymphocytosis, eosinophilia, swelling of the lymph glands and other symptoms. Other similarities were pointed out by Payne and de Rudder, such as an alkalosis during the time of incubation, which changes to acidosis at the outbreak of the rash.

According to the literature well developed nirvanol sickness improves the symptoms of chorea. Children show nirvanol sickness more frequently than do adults. Barbital and phenobarbital are also able to produce symptoms similar to those produced by nirvanol, although less frequently. Apparently, all of these . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Pediatric Department and the Laboratories of Mount Sinai Hospital.

Footnotes
Read at a Meeting of the American Pediatric Society, Rochester, N. Y., June 27, 1932.

These studies were carried out with the support of an "Allergy Fund" donated anonymously.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?